楊躍進，1958年生，籍貫江蘇靖江，心血管病和冠心病介入治療專家，阜外醫院主任醫師，博士生導師。1978-1982年畢業于蘇州醫學院醫學系，學士學位。1984-1989年在中國協和醫大研究生院心血管病專業攻讀碩、博士學位，從事急性心梗心功能測定、心室重構和心衰防治研究。1993和1996年分別在協和醫大破格晉升為副和正主任醫師；1998年獲博導資格；2000年享受國務院特貼。2002-2019年任副院長；2015-2019年任國家心臟中心副主任；兼任過心內科及介入、心衰（創建）和冠心病三大中心主任。

冠心病復雜、高危患者和病變微創介入技術難題攻克；探索中藥通心絡對急性心肌梗死微血管屏障功能保護，心肌無復流和機械并發癥的防治及機制；能提高治療急性心梗效果的骨髓干細胞及其外泌體新一代種子研發。

爆草黑丝美女|韩国19禁无遮挡啪啪无码网站|91精品国产自产精品男人的天堂|sm鞭打高潮喷水抽搐调教玩弄|果冻在线|日本大尺度吃奶呻吟视频|久久久久黄片|北条麻妃av免费观看|中文字幕一区二区人妻|亚洲最大天堂无码精品区,日韩 欧美 国产精品,国产肉丝袜在线观看,最爽无遮挡行房视频,成人H视频在线观看,糖心vlog冉冉,蜜桃产品一二三产区

1. Xu JY#, Xiong YY, Tang RJ, Jiang WY, Ning Y, Gong ZT, Huang PS, Chen GH, Xu J, Wu CX, Hu MJ, Xu J, Xu Y, Huang CR, Jin C, Lu XT, Qian HY, Li XD, Yang YJ*. Interleukin-5-induced eosinophil population improves cardiac function after myocardial infarction. Cardiovasc Res. 2022 Jul 20;118(9):2165-2178. (IF=13.081)

2．Xiong Y#, Tang R, Xu J, Jiang W, Gong Z, Zhang L, Ning Y, Huang P, Xu J, Chen G, Li X, Hu M, Xu J, Wu C, Jin C, Li X, Qian H, Yang Y*. Tongxinluo-pretreated mesenchymal stem cells facilitate cardiac repair via exosomal transfer of miR-146a-5p targeting IRAK1/NF-κB p65 pathway. Stem Cell Res Ther. 2022 Jul 7;13(1):289. (IF=8.096)

3. Cui K#, Fu R#, Yang J, Xu H, Yin D, Song W, Wang H, Zhu C, Feng L, Wang Z, Wang Q, Lu Y, Dou K*, Yang Y*. Admission Blood Glucose and 2-Year Mortality After Acute Myocardial Infarction in Patients With Different Glucose Metabolism Status: A Prospective, Nationwide, and Multicenter Registry. Front Endocrinol (Lausanne). 2022 Jun 15;13:898384. (IF=6.055)

4. Huang P#, Wang L, Li Q, Tian X, Xu J, Xu J, Xiong Y, Chen G, Qian H, Jin C, Yu Y, Cheng K, Qian L*, Yang Y*. Atorvastatin enhances the therapeutic efficacy of mesenchymal stem cells-derived exosomes in acute myocardial infarction via up-regulating long non-coding RNA H19. Cardiovasc Res. 2020 Feb 1;116(2):353-367. (IF=13.081)

5．Xu H#, Yang Y*, Wang C, Yang J，Li W, Zhang X, Ye Y, Dong Q, Fu R, Sun H, Yan X，Gao X, Wang Y, Jia X, Sun Y, Wu Y, Zhang J, Zhao W, Sabatine MS, Wiviott SD, for CAMI registry investigators. Association of hospital-level differences in care with outcomes among patients with acute ST-Segment elevation myocardial infarction in China. JAMA Network open. 2020;3(10):e2021677. (IF=11.64)

6．Chen G#, Xu C, Gillette TG, Huang T, Huang P, Li Q, Li X, Li Q, Ning Y, Tang R, Huang C, Xiong Y, Tian X, Xu J, Xu J, Chang L, Wei C, Jin C, Hill JA*, Yang Y*. Cardiomyocyte-derived small extracellular vesicles can signal eNOS activation in cardiac microvascular endothelial cells to protect against Ischemia/Reperfusion injury. Theranostics. 2020 Sep 23;10(25):11754-11774.  (IF=11.600)

7. Xu J#, Xiong YY, Li Q, Hu MJ, Huang PS, Xu JY, Tian XQ, Jin C, Liu JD, Qian L*, Yang YJ*. Optimization of Timing and Times for Administration of Atorvastatin-Pretreated Mesenchymal Stem Cells in a Preclinical Model of Acute Myocardial Infarction. Stem Cells Transl Med. 2019 Oct;8(10):1068-1083. (IF=7.655)

8．Xu B#, Redfors B*, Yang Y*, Qiao S, Wu Y, Chen J, Liu H, Chen J, Xu L, Zhao Y, Guan C, Gao R, Généreux P. Impact of Operator Experience and Volume on Outcomes After Left Main Coronary Artery Percutaneous Coronary Intervention. JACC Cardiovasc Interv. 2016 Oct 24;9(20):2086-2093. (IF=11.075)

9. Yang YJ#*, Kandzari DE, Gao Z, Xu B, Chen JL, Qiao SB, Li JJ, Qin XW, Yao M, Wu YJ, Yuan JQ, Chen J, Liu HB, Dai J, Chen T, Wang Y, Li W, Gao RL. Transradial versus transfemoral method of percutaneous coronary revascularization for unprotected left main coronary artery disease: comparison of procedural and late-term outcomes. JACC Cardiovasc Interv. 2010 Oct;3(10):1035-42.  (IF=11.075)

10. Yang YJ#*, Qian HY, Huang J, Geng YJ, Gao RL, Dou KF, Yang GS, Li JJ, Shen R, He ZX, Lu MJ, Zhao SH. Atorvastatin treatment improves survival and effects of implanted mesenchymal stem cells in post-infarct swine hearts. Eur Heart J. 2008 Jun;29(12):1578-90. (IF=35.855)